South Korean Pharmaceuticals & Biotech Undervalued over 20% based on DCF

ALTEOGEN

Market Cap: ₩19.5t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

SK Biopharmaceuticals

Market Cap: ₩7.7t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Hanmi Pharm

Market Cap: ₩5.8t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

GC Biopharma

Market Cap: ₩1.6t

A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.

Seegene

Market Cap: ₩1.5t

Manufactures and sells molecular diagnostics products worldwide.

Boryung

Market Cap: ₩815.2b

Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.

Ildong Pharmaceutical

Market Cap: ₩726.3b

Develops, manufactures, and sells pharmaceutical products in South Korea.

Medy-Tox

Market Cap: ₩671.3b

Operates as a biopharmaceutical company in South Korea.

3billion

Market Cap: ₩323.6b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

Hana Pharm

Market Cap: ₩177.4b

Develops and provides various pharmaceutical products in South Korea and internationally.

Jeil Pharma Holdings

Market Cap: ₩132.2b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

RP Bio

Market Cap: ₩52.0b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

Eagle Veterinary TechnologyLtd

Market Cap: ₩46.9b

Manufactures and sells animal health care products in South Korea.